Wiersinga WM - Search Results

1

Complete inhibition of rhTSH-, Graves' disease IgG-, and M22-induced cAMP production in differentiated orbital fibroblasts by a low-molecular-weight TSHR antagonist.

van Zeijl CJ, van Koppen CJ, Surovtseva OV, de Gooyer ME, Plate R, Conti P, Karstens WJ, Timmers M, Saeed P, Wiersinga WM, Miltenburg AM, Fliers E, Boelen A. van Zeijl CJ, et al. Among authors: wiersinga wm. J Clin Endocrinol Metab. 2012 May;97(5):E781-5. doi: 10.1210/jc.2011-2931. Epub 2012 Mar 14. J Clin Endocrinol Metab. 2012. PMID: 22419705

2

Therapeutic controversies. Retrobulbar radiation in Graves' ophthalmopathy.

Wiersinga W, Prummel MF. Wiersinga W, et al. J Clin Endocrinol Metab. 1995 Feb;80(2):345-7. doi: 10.1210/jcem.80.2.7852487. J Clin Endocrinol Metab. 1995. PMID: 7852487 No abstract available.

3

TR(beta)1 protein is preferentially expressed in the pericentral zone of rat liver and exhibits marked diurnal variation.

Zandieh Doulabi B, Platvoet-ter Schiphorst M, van Beeren HC, Labruyere WT, Lamers WH, Fliers E, Bakker O, Wiersinga WM. Zandieh Doulabi B, et al. Among authors: wiersinga wm. Endocrinology. 2002 Mar;143(3):979-84. doi: 10.1210/endo.143.3.8706. Endocrinology. 2002. PMID: 11861522

4

Graves' ophthalmopathy: a rational approach to treatment.

Wiersinga WM, Prummel MF. Wiersinga WM, et al. Trends Endocrinol Metab. 2002 Sep;13(7):280-7. doi: 10.1016/s1043-2760(02)00622-7. Trends Endocrinol Metab. 2002. PMID: 12163229 Review.

5

Epidemiology and prevention of Graves' ophthalmopathy.

Wiersinga WM, Bartalena L. Wiersinga WM, et al. Thyroid. 2002 Oct;12(10):855-60. doi: 10.1089/105072502761016476. Thyroid. 2002. PMID: 12487767 Review.

6

Myxedema coma.

Fliers E, Wiersinga WM. Fliers E, et al. Among authors: wiersinga wm. Rev Endocr Metab Disord. 2003 May;4(2):137-41. doi: 10.1023/a:1022985902253. Rev Endocr Metab Disord. 2003. PMID: 12766541 Review. No abstract available.

7

Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease.

Strieder TG, Prummel MF, Tijssen JG, Endert E, Wiersinga WM. Strieder TG, et al. Among authors: wiersinga wm. Clin Endocrinol (Oxf). 2003 Sep;59(3):396-401. doi: 10.1046/j.1365-2265.2003.01862.x. Clin Endocrinol (Oxf). 2003. PMID: 12919165

8

Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients.

Brokken LJ, Wiersinga WM, Prummel MF. Brokken LJ, et al. Among authors: wiersinga wm. J Clin Endocrinol Metab. 2003 Sep;88(9):4135-8. doi: 10.1210/jc.2003-030430. J Clin Endocrinol Metab. 2003. PMID: 12970276 Clinical Trial.

9

A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy.

Prummel MF, Terwee CB, Gerding MN, Baldeschi L, Mourits MP, Blank L, Dekker FW, Wiersinga WM. Prummel MF, et al. Among authors: wiersinga wm. J Clin Endocrinol Metab. 2004 Jan;89(1):15-20. doi: 10.1210/jc.2003-030809. J Clin Endocrinol Metab. 2004. PMID: 14715820 Clinical Trial.

10

Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study.

Wakelkamp IM, Tan H, Saeed P, Schlingemann RO, Verbraak FD, Blank LE, Prummel MF, Wiersinga WM. Wakelkamp IM, et al. Among authors: wiersinga wm. Ophthalmology. 2004 Aug;111(8):1557-62. doi: 10.1016/j.ophtha.2003.12.054. Ophthalmology. 2004. PMID: 15288988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

435 results

Search Page